Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$174,168.00
Agreement Date:
Apr 1, 2014 - Mar 31, 2016
Description:
A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of The Routine use of SSRIs at the Initiation of End-stage Renal Disease Treatment (ROSIE)
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 2C4
Reference Number:
236-2013-2014-Q4-00380
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2014-15 to 2015-16)

Recipient's Legal Name:
JASSAL, Sarbijt V
Research Organization:
University Health Network (Toronto)